How did FTXH's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on FTXH as a result. In 71 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

FTXH

AS OF

Aug 14 closing price

Price

$39.80

Change

-$0.23 (-0.57%)

Net Assets

986.96M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

FTXH

ETF ticker: NASDAQ

AS OF

Aug 14 closing price

Price

$39.80

Change

-$0.23 (-0.57%)

Net Assets

986.96M

FTXH

ETF ticker: NASDAQ

PRICE

CHANGE

NET ASSETS

FTXH stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on FTXH's trend?

The Aroon Indicator entered an Uptrend today. In 227 of 282 cases where FTXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq U... Show more

Category: #Health

Get AI intraday signals

FTXH

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

Intraday

View AI-Driven Trading for FTXH

Interact to see
Advertisement

A.I.Advisor

a Summary for FTXH with price predictions

Aug 14, 2026

FTXH in +0.31% Uptrend, rising for three consecutive days on August 13, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FTXH advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on FTXH as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 282 cases where FTXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for FTXH turned negative on August 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FTXH broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq U.S. Smart Pharmaceuticals TM Index. The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

Market Cap

The average market capitalization across the First Trust Nasdaq Pharmaceuticals ETF ETF is 69.97B. The market cap for tickers in the group ranges from 1.81B to 1.05T. LLY holds the highest valuation in this group at 1.05T. The lowest valued company is PRGO at 1.81B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was 1%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was 14%. SRPT experienced the highest price growth at 8%, while VCYT experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was -41%. For the same stocks of the ETF, the average monthly volume growth was -29% and the average quarterly volume growth was -45%